Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Microdose GLP OneMicrodosing evidence & price desk · Updated September 4, 2026

News

Microdose Provider Market Updates

Latest — updated August 10, 2026

Market-structure developments:

Brand 12-month subscriptions hold at $249/month

Ro, WeightWatchers, and LifeMD continue the first multi-month brand Wegovy plans launched March 31 — $329/$299/$249 on 3/6/12-month commitments — the narrowest brand-vs-compounded gap on record.

Monitored category — items publish only when newsworthy and sourced.

The provider-market category records verified operating changes: launches, closures, rebrands, acquisitions, and pharmacy or formulation changes. Each update is tied to a first-party or official confirmation before it affects a provider's directory record.

Category page indexable; items gated. An item appears here only with a primary source and an event date. We would rather show nothing than manufacture freshness.

What we watch in this category

Primary sources monitored

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.